Journal of Antibiotics 2018-03-14

Umezawamides, new bioactive polycyclic tetramate macrolactams isolated from a combined-culture of Umezawaea sp. and mycolic acid-containing bacterium

Shotaro Hoshino, Chin Piow Wong, Masahiro Ozeki, Huiping Zhang, Fumiaki Hayashi, Takayoshi Awakawa, Shumpei Asamizu, Hiroyasu Onaka, Ikuro Abe

Index: 10.1038/s41429-018-0040-4

Full Text: HTML

Abstract

New polycyclic tetramate macrolactams, Umezawamides A (1) and B (2) were isolated from a combined-culture of Umezawaea sp. RD066910 and mycolic-acid containing bacterium Tsukamurella pulmonis TP-B0596. Their planar structures and partial stereochemistries were determined based on the spectroscopic analysis, MMFF conformational search, and ECD calculations. Umezawamides are the first secondary metabolites isolated from the genus Umezawaea and they exhibited cytotoxicities to P388 murine leukemia cells. Furthermore, umezawamide A (1) showed growth inhibitory activity against Candida albicans.

Latest Articles:

Reclassification of Nocardia species based on whole genome sequence and associated phenotypic data

2018-04-04

[10.1038/s41429-018-0043-1]

Roquefortine J, a novel roquefortine alkaloid, from the deep-sea-derived fungus Penicillium granulatum MCCC 3A00475

2018-04-04

[10.1038/s41429-018-0046-y]

Correction to: Halistanol sulfates I and J, new SIRT1–3 inhibitory steroid sulfates from a marine sponge of the genus Halichondria

2018-03-27

[10.1038/s41429-017-0019-6]

Tolyprolinol, a new dipeptide from Tolypocladium sp. FKI-7981

2018-03-22

[10.1038/s41429-018-0041-3]

Cystargamide B, a cyclic lipodepsipeptide with protease inhibitory activity from Streptomyces sp.

2018-03-22

[10.1038/s41429-018-0044-0]

More Articles...